Gene Query: MRPL45

Dataset Description Geneva Score
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 34.4
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 31.48
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 31.48
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 28.67
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 25.27
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 21.85
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 20.01
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 19.56
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 15.08
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 15.08
Single-nucleotide-resolution mapping of HBV promoters using CAGE 14.92
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 14.66
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 14.31
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 13.95
Patient-derived luminal breast cancer xenografts with progestins 13.64
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 13.64
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 13.57
Genome wide expression change by RNF168 knocking down in NEC cells 13.25
NRDE2 negatively regulates nuclear exosome functions 13.07
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 12.93
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 12.45
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 12.38
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 12.38
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 12.08
Comprehensive comparative analysis of 5’ end RNA sequencing methods 11.82
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.45
Rorc disruption in human FG pancreatic cancer cells 11.29
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 11.06
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.9
TT-Seq captures the human transient transcriptome 10.87
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 10.63
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 10.61
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 10.45
Oncogenic MYC induces a dependency on the spliceosome in human cancer 9.83
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.77
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.5
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 9.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 9.05
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 9.01
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 8.83
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.82
Biological effect of chronic mistranslation in mammalian cells 8.76
Effect of from Human Umbilical Vein Endothelial Cells 8.75
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.73
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 8.66
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 8.6
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 8.59
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.47
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.47
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.35
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.35
Evolution of a transcriptional regulator from a transmembrane nucleoporin 8.33
RNA-seq in HepG2 and IMR90 cells 8.33
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 8.09
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 8.04
MOF acetyl transferase regulates transcription and respiration in mitochondria 8.02
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.96
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 7.91
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 7.9
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.76
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 7.76
Global analysis of enhancer targets: Mosaic-seq 7.65
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 7.59
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 7.59
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.52
Cellular response to hepatitis E virus (HEV) infection 7.43
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.42
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 7.4
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 7.38
RNA sequencing of human mammary epithelial cells 7.32
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.21
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.2
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.16
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.16
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 7.14
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 7.14
RNA-Seq with and without RNase treatment in PCa cell lines 7.12
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 6.99
Transcriptomic analyssis following EHMT1/2 inhibition 6.98
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 6.93
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 6.93
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.91
T47D RNA-seq and ChrRNA-seq data 6.91
RNA-seq of human aneuploid cell lines with Trisomy 21 6.91
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 6.78
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 6.78
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.76
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 6.75
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 6.75
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 6.75
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 6.63
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 6.59
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 6.57
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 6.56
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 6.56
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.54
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 6.51
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 6.48
Developmental stage specific chromosome architecture in human erythroid cells 6.48
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.47
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 6.38
Cell responses to dysregulated VZV-induced cell-cell fusion 6.38
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.31
Effect of mitochondria deficiency on senescence-associated gene expression 6.31
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.3
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 6.27
snRNAs as regulators of alternative splicing 6.2
Accurate annotation of human protein-coding small open reading frames 6.18
Impact of dieldrin on transcription in Jurkat T cells 6.11
RNAseq of HEK293 cells after Chtop knockdown 6.06
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.06
Dtx3L and Androgen Signaling in Prostate Cancer 6.05
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 6.03
Transcriptome sequencing of K-562 cells 6.03
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.97
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 5.94
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.92
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.89
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 5.88
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.88
Effect of Hotair overexpression in human breast cancer cell lines 5.88
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.85
Overexpression of NFIB and YBX1 in MCF-7 cells 5.85
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.82
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 5.79
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.78
RNA-seq analysis and shRNA screen of breast cancer 5.77
RNA-seq analysis of breast cancer 5.77
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.74
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 5.69
RNAseq Study in CC-671 Treated Cal-51 Cells 5.66
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.6
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 5.51
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.48
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 5.48
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.46
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 5.43
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 5.41
DART-seq: an antibody-free method for global m6A detection 5.4
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.39
scRNASeq analysis of cycling cardiomyocytes 5.38
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 5.36
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 5.28
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 5.28
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.26
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 5.23
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 5.22
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.21
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 5.19
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 5.17
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.16
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.13
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.09
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.09
Transcriptional effect of ETV1 knockdown in melanoma cells 5.08
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.07
Landscape and variation of RNA secondary structure across the human transcriptome 5.07
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 5.03
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.99
miRNAs affected by antagomiR-17 treatment 4.97
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.97
An integrative analysis of non-coding regulatory DNA variations associated with autism 4.9
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.88
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.86
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 4.85
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 4.84
Paxillin regulates genomic networks in prostate cancer [LNCaP] 4.79
A map of gene expression in neutrophil-like cell lines 4.78
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.74
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.74
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 4.71
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 4.7
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.61
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.61
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.53
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.53
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.53
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.53
Genome wide expression change by RNF168 knocking down in MCF-7 cells 4.52
Control of prostate tumour growth by the long non-coding RNA GHSROS 4.51
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 4.5
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 4.5
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.5
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.49
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.47
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.47
Gene expression changes due to PARP knockdown in human cells 4.47
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.45
In situ CAPTURE of chromatin interactions by biotinylated dCas9 4.45
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 4.45
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.44
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.42
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.4
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 4.38
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.36
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.36
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.35
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 4.34
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.33
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 4.31
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 4.31
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.29
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.28
RNA-seq analysis of differentiating human erythroblasts 4.28
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.24
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.22
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 4.22
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.18
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 4.18
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 4.16
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 4.15
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 4.15
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.14
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.14
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 4.1
Identification of Nrf2 regulated genes by RNA sequencing 4.06
Nrf2 regulated genes in A549 cells 4.06
Functional role of CPPED1 in trophoblasts. 4.05
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 4.05
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 4.04
RNA-seq analysis of RALD iPSCs after in vitro differentiation 4.03
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.01
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.0
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.99
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.99
Differentially expressed vascular development genes for iPSC-ECs from CDI 3.92
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 3.91
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 3.91
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 3.88
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 3.88
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.87
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.87
Transcriptome analysis of U87 cells upon LINC00152 knockdown 3.86
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 3.85
RNA editing in nascent RNA affects pre-mRNA splicing 3.83
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.81
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 3.8
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 3.8
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.79
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.77
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.74
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 3.68
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.68
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.67
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 3.67
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.66
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.62
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.62
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.6
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.55
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.48
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.48
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.46
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 3.45
The cohesin complex prevents Myc-induced replication stress 3.45
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.37
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.36
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.31
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.28
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.28
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 3.24
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.24
KLF6-dependent transcription in renal cancer cells 3.22
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.22
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.21
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.21
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.2
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.2
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.18
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.16
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 3.14
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 3.1
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 3.03
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.02
Fusion discovery in breast cancer cell line 3.02
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.01
PRDM1 inhibits proliferation of human colon cancer organoids 3.0
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.0
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.0
Cajal bodies are linked to genome conformation [RNA-Seq] 2.99
Cajal bodies are linked to genome conformation 2.99
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.98
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.98
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.96
High-throughput sequencing of pluripotent cells 2.95
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 2.93
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.87
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 2.87
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 2.86
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.86
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.83
The pause-initiation limit restricts transcription activation in human cells 2.8
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.78
K562 polyA RNA-Seq 2.78
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.76
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.76
Effect of PBK knockdown on C4-2 cell transcriptome 2.76
Transcriptomic analysis of the HOTAIR-regulated genes 2.76
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.74
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.7
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 2.69
Knockdown of ADNP in HCT116 colon cancer cells 2.69
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.69
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.68
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 2.67
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.66
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.66
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 2.63
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 2.63
Impact on erythroid progenitor type on erythroid differntiation 2.6
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 2.58
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.58
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.55
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.45
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.44
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.44
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.44
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 2.44
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.44
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.43
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.38
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.38
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.36
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.36
Differential gene expression profiles in imatinib-resistant cell lines 2.34
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.31
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 2.28
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.28
Role of COP1 on MAP kinase transcriptional output in melanoma 2.2
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.19
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.19
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.17
Dynamic 3D chromosomal landscapes in acute leukemia 2.14
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.14
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.14
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.11
Effect of ILF3 on translation during homeostasis and the antiviral response 2.11
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.1
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.1
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.07
Gene expression profile in breast cancer cells 2.07
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.06
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.06
A20 regulates canonical wnt-signaling through an interaction with RIPK4 2.06
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.06
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 2.06
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.01
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 1.99
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 1.98
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.97
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.95
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.94
RNA sequencing of mechanically strained NHEKs and control NHEKs 1.94
N6-methyladenine DNA Modification in Glioblastoma 1.93
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.93
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.91
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.91
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.9
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.89
Chromatin landscape of human visceral and subcutaneous adipocytes 1.88
Positively selected enhancer elements endow tumor cells with metastatic competence 1.85
Function and hormonal regulation of GATA3 in human first trimester placentation 1.85
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.85
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.84
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.84
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.82
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.78
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.78
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.77
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.77
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.76
The Genetic Landscape of Diamond-Blackfan Anemia 1.76
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.73
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.73
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.72
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.71
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.71
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.7
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.62
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.6
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.57
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.57
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 1.57
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.57
The DPYSL2 gene connects mTOR and schizophrenia 1.57
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.5
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.49
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.47
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 1.46
Transcriptome-wide modulation of splicing by the exon junction complex 1.43
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.43
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.42
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.41
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.39
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.37
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.36
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.36
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.35
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.34
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.33
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.33
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.32
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.31
Functional significance of the HIV-1 Tat signature amino acid residues 1.27
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.22
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.19
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.18
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.17
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.17
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.16
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.14
Role of FGFR1 in neuronal devlopment 1.13
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.12
mRNA recovered upon RNF219 IP. [RNA-IP] 1.08
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.05
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.03
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.0
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.99
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.98
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.98
Single-cell analysis of human kidney organoids 0.97
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.96
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.9
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.9
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.9
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.86
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.86
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.85
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.85
Leucegene: AML sequencing (part 6) 0.84
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.84
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.84
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.84
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.84
CDK4/6 inhibitor resistance in prostate cancer 0.81
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.77
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.73
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 0.71
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.69
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.64
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.64
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.64
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.61
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.61
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.6
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.59
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.55
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.54
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.53
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.49
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.46
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.44
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.42
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.42
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.41
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.39
RNA-Seq from human ILC transitional populations 0.39
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 0.39
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.37
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.37
Hepatic transcriptome of pediatric hepatoblastoma. 0.37
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.36
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.35
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.35
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.32
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.31
Transcriptional landscape changes during human embryonic stem cell derivation 0.3
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.28
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.28
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.27
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.26
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.23
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.22
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.22
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.22
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.22
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.2
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.2
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.19
Identification of a LIF-responsive replication-competent human β cell 0.18
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.18
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.18
The MEF2B Regulatory Network - RNA-seq data 0.18
The MEF2B Regulatory Network 0.18
Global transcriptome analysis of WT versus HEB-/- hESCs 0.17
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.17
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.15
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.15
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 0.09
Enhancer activation during EGF response 0.09
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.04
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.03
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.02
Determining mRNA half-lives on a transcriptome-wide scale 0.02
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.02
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.02
Gene expression analysis in response to hypoxic pathway inhibition 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation